Scott Sauer, DO
Interventional Pain Medicine · Myrtle Beach, SCNPI 1679681647
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $841 of the $1,047 with a category attached, or 80.3%. Medtronic accounts for 95.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $486 and has fallen 91.5% since, to $41 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in SC, where the typical reported total is $3,940.
Across 25 payments — averaging $41.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$999
- Abbott$17
- Boston Scientific$16
- Zyla Life Sciences, Inc.$15
What the payments were for
- Travel & lodging$20620%
- Food & beverage$84180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $999 |
| Abbott | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$327
- SYNCHROMED$206
- INTELLIS$120
How this compares
$1,047 in reported general payments places this provider in the 20th percentile of 38 interventional pain medicine providers in South Carolina.
See all interventional pain medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 121 | $161,222 |
| Xtampza ErOxycodone Myristate | 74 | $77,856 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,475 | $52,205 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,581 | $38,570 |
| PercocetOxycodone Hcl/Acetaminophen | 12 | $34,640 |
| Fentanyl | 252 | $34,499 |
| Oxycodone Hcl | 1,196 | $29,009 |
| Morphine Sulfate ErMorphine Sulfate | 543 | $17,695 |
| Gabapentin | 1,033 | $15,327 |
| Hysingla ErHydrocodone Bitartrate | 12 | $10,727 |
| Methadone Hcl | 321 | $10,064 |
| Buprenorphine | 38 | $9,698 |
| MovantikNaloxegol Oxalate | 20 | $9,649 |
| Pregabalin | 259 | $9,099 |
| Lidocaine | 55 | $7,443 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Myrtle Beach
- Kenneth WenzMyrtle Beach$61
- Mark NethertonMt Pleasant$102K
- Marion McMillanSeneca$89K
- Jason RosenbergMurrells Inlet$82K
- Ryan NoblesMt Pleasant$43K
- Justin HutchesonGreenville$23K
- Joshua BighamSpartanburg$14K
- David RoweBluffton$9K
- William DurrettAiken$8K
- Kenneth GrosslightWest Columbia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.